Article citationsMore>>

Turtle, C.J., et al. (2017) Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated with CD19-Specific Chimeric Antigen Receptor-Modified T Cells after Failure of Ibrutinib. Journal of Clinical Oncology, 35, 3010-3020.
https://doi.org/10.1200/JCO.2017.72.8519

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top